Posted by Michael Wonder on 21 May 2020
AstraZeneca secures orders for virus vaccine under testing
21 May 2020 - Drug maker AstraZeneca has secured the first agreements Thursday for 400 million doses of a COVID-19 vaccine that is being trialed.
Drug maker AstraZeneca said Thursday it had secured its first agreements for 400 million doses of a COVID-19 vaccine it is testing, bolstered by an investment from the U.S. vaccine agency.
The Anglo-Swedish company reported it had received more than $1 billion from the U.S. Biomedical Advanced Research and Development Authority for the development, production and delivery of the vaccine, starting this fall.
